EU and US could reach trade deal this weekend - Reuters
In a challenging market environment, Tilray Inc (NASDAQ:TLRY) stock has recorded a new 52-week low, dipping to $0.41. The cannabis company, with a market capitalization of $403 million, has been navigating through regulatory hurdles and intense competition. Despite maintaining healthy liquidity with a current ratio of 2.62, the company has seen its share price steadily decline, reflecting broader industry trends and investor sentiment. According to InvestingPro analysis, the stock appears undervalued at current levels, with analysts setting price targets ranging from $0.65 to $2.50. Over the past year, Tilray’s stock has experienced a significant downturn, with a 1-year change showing a sharp decrease of -76.38%. Despite these challenges, the company has achieved revenue growth of 11.22% over the last twelve months. This latest price level underscores the volatility and the pressures facing the cannabis sector, as companies like Tilray strive to adapt and position themselves for future growth amidst a complex and evolving landscape. Discover 12 additional key insights about Tilray with InvestingPro’s comprehensive analysis and research reports.
In other recent news, Tilray Inc. reported its third-quarter 2025 financial results, revealing a significant revenue miss and a larger-than-expected net loss. The company’s earnings per share came in at -$0.87, far below the forecasted -$0.0433, with revenue reported at $185.78 million against an anticipated $213.56 million. Tilray has revised its fiscal 2025 revenue guidance to a range of $850-900 million. Additionally, Tilray announced plans to hold a special meeting of stockholders to seek approval for a reverse stock split, aiming to maintain compliance with Nasdaq’s listing requirements.
Tilray has made considerable progress in its financial structure, reducing total debt by approximately $76 million during fiscal 2025. As of February 28, 2025, the company reported a cash and marketable securities balance exceeding $248 million. Analyst firm Needham recently adjusted its price target for Tilray shares to $20.00 from $28.00, maintaining a Buy rating, while Jefferies also cut its price target to $1.50 from $2.50, but continued to recommend a Buy rating. Both firms cited strategic shifts and macroeconomic factors as reasons for their adjustments.
Tilray’s CEO, Erwin Simon, emphasized the company’s focus on profitability over immediate revenue growth. The company is also exploring innovative strategies, including the use of cryptocurrency payments and AI in greenhouse operations. These recent developments reflect Tilray’s ongoing efforts to streamline operations and improve financial performance amidst a challenging economic environment.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.